Telo Genomics Corp (3D0A) Ratios
Telo Genomics Corp Ratios
DE:3D0A's free cash flow for Q4 2026 was $-544.82K. For the 2026 fiscal year, DE:3D0A's free cash flow was increased by $206.24K and operating cash flow was $-751.06K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Sep 25 | Sep 24 | Jun 22 | Sep 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.21 | 2.25 | 2.45 | 14.66 | 2.94 |
| Quick Ratio | 0.21 | 2.25 | 2.45 | 14.66 | 2.94 |
| Cash Ratio | 0.16 | 1.99 | 2.12 | 14.17 | 2.61 |
| Solvency Ratio | -1.02 | -6.82 | -7.12 | -8.93 | -2.99 |
| Operating Cash Flow Ratio | -0.74 | -5.88 | -6.55 | -9.44 | -3.17 |
| Short-Term Operating Cash Flow Coverage | -1.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -1.74M | $ 495.94K | $ 543.45K | $ 2.56M | $ 643.89K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 2.41 | 0.00 | 0.00 | 0.01 | 0.03 |
| Debt-to-Equity Ratio | -0.91 | 0.00 | 0.00 | 0.02 | 0.05 |
| Debt-to-Capital Ratio | -10.37 | 0.00 | 0.00 | 0.02 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.05 |
| Financial Leverage Ratio | -0.38 | 1.77 | 1.64 | 1.09 | 1.51 |
| Debt Service Coverage Ratio | -1.31 | -541.38 | -580.59 | -379.98 | -43.36 |
| Interest Coverage Ratio | -11.44 | -544.29 | -589.16 | -398.98 | -49.40 |
| Debt to Market Cap | 0.35 | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest Debt Per Share | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.53 | 0.29 | 0.30 | 1.30 | 0.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 99.34% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 106.33% | 100.61% | 99.80% | 98.14% | 94.72% |
| Return on Assets (ROA) | -385.19% | -298.34% | -280.95% | -74.49% | -106.25% |
| Return on Equity (ROE) | 146.00% | -527.93% | -459.79% | -81.07% | -160.17% |
| Return on Capital Employed (ROCE) | 141.70% | -524.75% | -460.70% | -81.36% | -160.79% |
| Return on Invested Capital (ROIC) | 1560.71% | -524.75% | -460.70% | -81.36% | -160.79% |
| Return on Tangible Assets | -385.19% | -298.34% | -285.80% | -74.92% | -107.76% |
| Earnings Yield | -57.58% | -28.17% | -20.54% | -10.06% | -17.29% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | -1844.56 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 1844.56 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | -0.03 | -0.03 | -0.03 | -0.04 |
| Free Cash Flow Per Share | -0.02 | -0.03 | -0.03 | -0.03 | -0.04 |
| Dividend Paid and CapEx Coverage Ratio | -84.86 | -716.53 | -480.68 | -71.25 | -129.12 |
| Capital Expenditure Coverage Ratio | -84.86 | -716.53 | -480.68 | -71.25 | -129.12 |
| Operating Cash Flow Coverage Ratio | -1.10 | 0.00 | 0.00 | -44.87 | -27.99 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -40.11% | -24.16% | -18.66% | -8.68% | -15.71% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.74 | -3.55 | -4.87 | -9.94 | -5.78 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -2.54 | 18.74 | 22.38 | 8.06 | 9.27 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.49 | -4.14 | -5.36 | -11.52 | -6.37 |
| Price-to-Operating Cash Flow Ratio | -2.52 | -4.14 | -5.37 | -11.68 | -6.42 |
| Price-to-Earnings Growth (PEG) Ratio | 0.07 | 0.19 | 0.26 | -0.17 | 0.12 |
| Enterprise Value Multiple | -2.44 | -3.30 | -4.65 | -8.94 | -5.48 |
| Enterprise Value | 5.12M | 8.86M | 12.41M | 18.32M | 6.30M |
| EV to EBITDA | -2.44 | -3.30 | -4.65 | -8.94 | -5.48 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -3.18 | -3.80 | -5.04 | -10.06 | -5.59 |
| EV to Operating Cash Flow | -3.22 | -3.81 | -5.05 | -10.21 | -5.63 |
| Tangible Book Value Per Share | -0.02 | 0.01 | 0.01 | 0.04 | 0.03 |
| Shareholders’ Equity Per Share | -0.02 | 0.01 | 0.01 | 0.04 | 0.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.00 | -0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.02 | -0.03 | -0.04 | -0.04 | -0.04 |
| Tax Burden | 0.99 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.06 | 1.01 | 1.00 | 1.00 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.69 | 0.86 | 0.91 | 0.85 | 0.90 |
Currency in CAD
